Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest ...

AbbVie reached a deal with the Trump administration on drug prices in exchange for being exempted from tariffs and future ...

Nearly 1.5 million Americans and nearly 5% of women over the age of 55 have rheumatoid arthritis (RA), an incurable ...

Rheumatoid arthritis patients often don't notice disease flares until symptoms have already worsened substantially. As joint ...

A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide ...

Lynk’s zemprocitinib commercial partner, Simcere, will now continue the JAK inhibitor’s development across China in RA.

A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Patients with rheumatoid arthritis (RA) who receive immune checkpoint inhibitor (ICI) therapy for cancer do not appear to face higher mortality compared against patients without RA receiving the same ...

Many ingredients in herbal tea can interact with prescription medications. Blood thinners, transplant medications, and antidepressants are just a few of the medications that should be avoided.